Dual blockade of renin-angiotensin system

BMJ

Volumn 322, Issue 7295, 2001, Pages 1183-

  Mccormack, James ^a   Levine, Marc ^a   Mogensen, Carl Erik ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CANDESARTAN; CREATININE; LISINOPRIL; UREA;

BLOOD PRESSURE; CLINICAL TRIAL; HUMAN; HYPERTENSION; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STATISTICAL ANALYSIS;

ANTIHYPERTENSIVE AGENTS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; RENIN-ANGIOTENSIN SYSTEM;

EID: 0035849328     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.322.7295.1183     Document Type: Letter

References (2)

1. Mogensen CE, Neldam S, Tikkanen I, Oren S, Viskoper R, Watts RW, et al. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study [with commentary by A Berger]. BMJ 2000; 321: 1440–1444. (9 December.)
2. Adler AI, Stratton IM, Neil HAW, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412–419.